Pneumococcal 20-valent Conjugate Vaccine (Walvax Biotech)

20价肺炎球菌多糖结合疫苗 (沃森生物)

Report date: 2025/12/29 15:30:19

Base Information

Drug NamePneumococcal 20-valent Conjugate Vaccine (Walvax Biotech)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Conjugated vaccine +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesWalvax Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsPneumococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A